Advances in Cancer Research: Volume 69
- Hardback | 256 pages
- 156 x 228 x 22mm | 598.75g
- 10 Sep 1996
- Elsevier Science Publishing Co Inc
- Academic Press Inc
- San Diego, United States
Other books in this series
21 Nov 2012
10 Jul 2012
02 Nov 2011
12 Sep 2009
16 Aug 2011
28 Sep 2004
02 May 1997
02 Nov 2017
31 Jul 2013
22 Apr 1999
01 Dec 2010
29 Dec 2010
21 Dec 2007
11 Feb 2015
02 Jul 2015
21 May 2012
16 Mar 2015
08 Mar 2002
"Excellent, highly informative, in-depth reviews... expertly written, up-to-date, and well-referenced."
--JOURNAL OF MEDICINAL CHEMISTRY
Table of contents
H. Varmus, The Pastorian: A Legacy of Louis Pasteur.
H. Okayama, A. Nagata, S. Jinno, H. Murakami, K. Tanaka, and N. Nakashima, Cell Cycle Control in Fission Yeast and Mammals: Identification of New Regulatory Mechanisms:
Life Cycle of Fission Yeast.
Cell Cycle Start Control of Fission Yeast.
Cell Cycle Start Control of Mammals.
Mitotic Start Control of Fission Yeast.
Mitotic Start Control of Mammals.
N. Mandahl, Cytogenetics and Molecular Genetics of Bone and Soft Tissue Tumors:
Cytogenetic and Major Molecular Genetic Findings.
Aberrations Shared by Several Tumor Types.
Diagnosis and Prognostication Based on Genetic Analysis.
H. Tapiovaara, R. Alitalo, and A. Vaheri, Plasminogen Activation on Tumor Cell Surface and Its Involvement in Human Leukemia:
Components of Plasminogen Activation.
Activation of Plasminogen on Cell Surface.
Regulators of Plasminogen Activation.
Internalization of uPA.
Plasminogen Activators in Tumors.
Plasminogen Activators in Cell Migration.
Plasminogen Activation and Leukemia.
N. Bouck, V. Stellmach, and S. Hsu, How Tumors Become Angiogenic:
Development of an Angiogenic Phenotype.
Therapeutic Strategies Targeting Tumor Angiogenesis.
P.L. Stern, Immunity to Human Papillomavirus-Associated Cervical Neoplasia:
Immunological Recognition of HPV in Cervical Neoplasia.
Evasion of Immune Surveillance.
Prospects for Immune Intervention.
D.J. Moss, C. Schmidt, S. Elliott, A. Suhrbier, S. Burrows, and R. Khanna, Strategies Involved in Developing an Effective Vaccine to EBV-Associated Diseases:
Humoral Response to EBV Infection.
CTL Response to EBV Infection.
Developing a Vaccine for EBV.
Vaccines and Immunotherapy for EBV-Associated Diseases.